David Peick Sonne

David Peick Sonne

Clinical Associate Professor

Member of:

  • Clinical Pharmacology


  1. Published

    Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1

    Sonne, David Peick, Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Oct 2014, In: European Journal of Endocrinology. 171, 4, p. 407-419 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart.

    Sonne, David Peick, Engstrøm, Thomas & Treiman, M., 2007, In: Regulatory Peptides. 146, 1-3, p. 243-9 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: A randomised, double-blind, active-comparator, non-inferiority clinical trial

    Kårhus, M. L., Brønden, A., Forman, Julie Lyng, Haaber, A., Knudsen, E., Langholz, Ebbe, Dragsted, Lars Ove, Hansen, S. H., Krakauer, M., Vilsbøll, Tina, Sonne, David Peick & Knop, Filip Krag, 2022, In: The Lancet Gastroenterology and Hepatology. 7, 10, p. 922-931 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential

    Brønden, Andreas, Hansen, M., Sonne, David Peick, Rohde, U., Vilsbøll, Tina & Knop, Filip Krag, 1 Feb 2015, In: Diabetes, Obesity and Metabolism. 17, 2, p. 116-120 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential

    Brønden, Andreas, Hansen, M., Sonne, David Peick, Rohde, U., Vilsbøll, Tina & Knop, Filip Krag, 1 Feb 2015, In: Diabetes, Obesity and Metabolism. 17, 2, p. 116-120 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Single-dose Tadalafil Reduces Opening Urethral Pressure: A Randomized, Double-blind, Placebo-controlled, Crossover Trial in Healthy Women

    Christoffersen, T., Riis, T., Sonne, David Peick & Klarskov, Niels, 2024, In: International Urogynecology Journal. 35, 3, p. 723-729

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

    Hemmingsen, B., Schroll, J. B., Lund, S., Wetterslev, J., Gluud, C., Vaag, Allan, Sonne, David Peick, Lundstrøm, Lars Hyldborg & Almdal, Thomas Peter, 2013, In: Cochrane Database of Systematic Reviews. 4, 56 p., CD009008.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects

    Jensen, T. L., Brønden, Andreas, Karstoft, Kristian, Sonne, David Peick & Christensen, Mikkel Bring, 2024, In: Patient Preference and Adherence. 18, p. 373-382 10 p.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    The bile-gut axis and metabolic consequences of cholecystectomy

    Lange, A. H., Pedersen, M. G., Ellegaard, A. M., Nerild, H. H., Brønden, Andreas, Sonne, David Peick & Knop, Filip Krag, 2024, In: European Journal of Endocrinology. 190, 4, p. R1-R9 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity

    Jensen, T. L., Brønden, Andreas, Karstoft, Kristian, Sonne, David Peick & Christensen, Mikkel Bring, 2023, In: Drugs of the Future. 48, 3, p. 179-196 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 1780933